NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
64 hedge funds and large institutions have $21.4M invested in Northwest Biotherapeutics, Inc. Common stock in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
62% less call options, than puts
Call options by funds: $132K | Put options by funds: $347K
65% less capital invested
Capital invested by funds: $61M → $21.4M (-$39.6M)
Holders
64
Holding in Top 10
1
Calls
$132K
Puts
$347K
Top Buyers
| 1 | +$268K | |
| 2 | +$186K | |
| 3 | +$163K | |
| 4 |
Renaissance Technologies
New York
|
+$154K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$113K |
Top Sellers
| 1 | -$1.41M | |
| 2 | -$820K | |
| 3 | -$506K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$260K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$258K |